Greg Zapotoczny, PhD
Staff Scientist
greg@ellison.usc.edu
Greg is a member of the Ruderman Laboratory at the Ellison Institute, where he specifically works with our Drug Development team. As a member of the Drug Development team, Greg is helping to develop novel anti-androgens for prostate cancer therapy and new screening techniques for new non-AR therapeutic targets. Greg earned his BS and MS in Microbiology from the University of Wroclaw (Poland). He earned his PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. Outside of work, Greg is an avid hiker and ballroom dancer. 
Greg Zapotoczny, PhD
Staff Scientist
greg@ellison.usc.edu
Greg is a member of the Ruderman Laboratory at the Ellison Institute, where he specifically works with our Drug Development team. As a member of the Drug Development team, Greg is helping to develop novel anti-androgens for prostate cancer therapy and new screening techniques for new non-AR therapeutic targets. Greg earned his BS and MS in Microbiology from the University of Wroclaw (Poland). He earned his PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. Outside of work, Greg is an avid hiker and ballroom dancer.